Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2686

PDF: 982

HTML: 31
Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Valeria Corazza, Francesco Cusano, Ornella De Pità, Luigi Rossi, G. Giovanni Virno

28-12-2021

https://doi.org/10.4081/dr.2022.9454

4113

PDF: 665

APPENDIX: 172

HTML: 15
Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study

Christa Ky, Brian Swasdibutra, Shaadi Khademi, Sheetal Desai, Vivian Laquer, Sergei A. Grando

16-03-2015

https://doi.org/10.4081/dr.2015.5804

2677

PDF: 1133

HTML: 248
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Paolo Dapavo, Matteo Megna, Marina Talamonti

09-08-2024

https://doi.org/10.4081/dr.2024.9999

1739

PDF: 669

HTML: 94
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi

14-03-2022

https://doi.org/10.4081/dr.2022.9091

2625

PDF: 632

HTML: 6
Blue diode laser as supportive therapy for the management of vulvar lichen sclerosus

Serena Bergamo, Margherita Gobbo, Silvia Chimenton, Giorgia D'Angelo, Luca Guarda Nardini, Alessandro Gatti

09-08-2024

https://doi.org/10.4081/dr.2024.10046

2388

PDF: 791

SUPPLEMENTARY MATERIAL: 260

HTML: 142
Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

Alhanouf Bin Dakhil, Asem Shadid, Saad Altalhab

19-05-2023

https://doi.org/10.4081/dr.2023.9703

4784

PDF: 937

APPENDIX 1: 142

HTML: 49
Regenerative therapies in lichen sclerosus genitalis patients and possible efficacy in preventing squamous cell carcinoma development: a long-term follow-up pilot study

Marinella Tedesco, Barbara Bellei, Lavinia Alei, Monia Di Prete, Carlo Cota, Tiziano Pallara, Antonio Bonadies, Alessandra Latini, Stefania De Fazio, Emilia Migliano

27-11-2024

https://doi.org/10.4081/dr.2024.10079

756

PDF: 466

HTML: 21
LASMIK laser biorevitalization: mechanisms and therapeutic experience

Sergey Vladimirovich Moskvin, Aleksandr Agubechirovich Khadartsev

28-12-2020

https://doi.org/10.4081/dr.2020.8996

1625

PDF: 448

HTML: 27
Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp

Uwe Wollina, Andreas Schreiber, Knut Merla, Gunter Haroske

e57

13-12-2011

https://doi.org/10.4081/dr.2011.e57

1884

PDF: 723

HTML: 1024
Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino

25-06-2020

https://doi.org/10.4081/dr.2020.8642

1352

PDF: 751

HTML: 8
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

1058

PDF: 563

HTML: 73
Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

15-04-2024

https://doi.org/10.4081/dr.2024.9967

1039

PDF: 553

HTML: 29
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

11-11-2024

https://doi.org/10.4081/dr.2024.10140

989

PDF: 521

SUPPLEMENTARY MATERIAL: 153

HTML: 16
Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole

19-06-2023

https://doi.org/10.4081/dr.2023.9755

851

PDF: 415

HTML: 17
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

17-03-2022

https://doi.org/10.4081/dr.2022.9282

1162

PDF: 825

HTML: 41
Vitiligo: What’s old, what’s new

Mariabeatrice Bertolani, Eleonora Rodighiero, Maria Beatrice de Felici del Giudice, Torello Lotti, Claudio Feliciani, Francesca Satolli

15-09-2021

https://doi.org/10.4081/dr.2021.9142

2652

PDF: 1145

HTML: 207
New and emerging therapies in cutaneous T-cell lymphoma

Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, Paolo Fava, Pietro Quaglino

02-10-2024

https://doi.org/10.4081/dr.2024.10002

1086

PDF: 589

HTML: 94
Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus

Pati Aji Achdiat, Stephanie Widjaja, Oki Suwarsa, Reiva Farah Dwiyana, Reti Hindritiani, Endang Sutedja, Hendra Gunawan, Hermin Aminah Usman, Fathia Rianty, Retno Hesty Maharani

30-01-2024

https://doi.org/10.4081/dr.2024.9754

883

PDF: 537

HTML: 26
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

1139

PDF: 620

HTML: 21
Refractory pityriasis rubra pilaris treated with abrocitinib

Filip Rob

09-01-2025

https://doi.org/10.4081/dr.2025.10105

406

PDF: 273

HTML: 11
Optimizing targeted therapy for metastatic melanoma: a combination of encorafenib and trametinib beyond standard protocols

François Pélouard, Valérie Chedru-Legros, Catherine Nganoa, Anne Dompmartin, Jean-Matthieu L'Orphelin

15-04-2025

https://doi.org/10.4081/dr.2025.10036

792

PDF: 307

SUPPLEMENTARY MATERIAL: 79

HTML: 4
Inflammatory seborrheic keratosis resolution after hyperbaric oxygen therapy: Case presentation and pathophysiology review

Karin Elman-Shina, Monica Elman, Shai Efrati

18-03-2021

https://doi.org/10.4081/dr.2021.8871

4130

PDF: 743

HTML: 32
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

1057

PDF: 546

HTML: 19
A microRNA focus on acne

Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

02-02-2024

https://doi.org/10.4081/dr.2024.9902

1081

PDF: 717

HTML: 57

1 - 25 of 73 items 1 2 3 > >>

Search

Search Results

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study

Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Blue diode laser as supportive therapy for the management of vulvar lichen sclerosus

Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

Regenerative therapies in lichen sclerosus genitalis patients and possible efficacy in preventing squamous cell carcinoma development: a long-term follow-up pilot study

LASMIK laser biorevitalization: mechanisms and therapeutic experience

Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Treatment satisfaction among patients with psoriasis in Saudi Arabia

Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Vitiligo: What’s old, what’s new

New and emerging therapies in cutaneous T-cell lymphoma

Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus

Erythrodermic psoriasis improved by tildrakizumab

Refractory pityriasis rubra pilaris treated with abrocitinib

Optimizing targeted therapy for metastatic melanoma: a combination of encorafenib and trametinib beyond standard protocols

Inflammatory seborrheic keratosis resolution after hyperbaric oxygen therapy: Case presentation and pathophysiology review

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

A microRNA focus on acne

authors

reviewers

Categories

indexing

dermatopathology